Geovax to present at the noble capital markets twentieth annual emerging growth equity conference

Atlanta, nov. 26, 2024 (globe newswire) -- geovax labs, inc. (nasdaq: govx), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its chairman & ceo, david dodd, will present at noblecon20 - the noble capital markets twentieth annual emerging growth equity conference taking place december 2-5, 2024 in boca raton, fl.
NE Ratings Summary
NE Quant Ranking